UK foot and mouth lab leaks again

A Surrey, UK, lab thought to be the linkurl:source;http://www.the-scientist.com/news/display/53474/ of a foot and mouth disease (FMD) outbreak in August again ran afoul of biosafety practices last week, when a leaking valve likely released live FMD virus into a contained drainage system. Merial, a company on the site that makes FMD vaccine, had been banned from using live virus after the August outbreak, but the government restored its license to work with FMD earlier this month when biosafety

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A Surrey, UK, lab thought to be the linkurl:source;http://www.the-scientist.com/news/display/53474/ of a foot and mouth disease (FMD) outbreak in August again ran afoul of biosafety practices last week, when a leaking valve likely released live FMD virus into a contained drainage system. Merial, a company on the site that makes FMD vaccine, had been banned from using live virus after the August outbreak, but the government restored its license to work with FMD earlier this month when biosafety measures were upgraded. The leak, which occurred on Monday (November 19), came to light when the workers noticed a shortfall in the amount of virus being recovered in the vaccine production process, according to a Department for Environment, Food and Rural Affairs (Defra) linkurl:report.;http://www.defra.gov.uk/corporate/ministers/statements/hb071122.htm Engineers called to inspect the system found that problem lay in a valve separating a line carrying live virus from a line carrying waste on its way to a chemical treatment facility. Merial reported the problem to Defra late Tuesday afternoon. Inspectors who visited the site Wednesday said they believe that no virus escaped into the environment. "The extensive layers of biosecurity that we require?effectively contained the virus in the closed, re-lined drainage system before deactivation in the chemical treatment facility," Defra's report states. But the incident raises the question of whether the facility is equipped to be handling live virus at all, according to UK linkurl:media;http://www.timesonline.co.uk/tol/news/uk/article2922474.ece reports. The company's license to work with both FMD and bluetongue virus have again been suspended.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Eppendorf Logo

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

Evident Logo

EVIDENT's New FLUOVIEW FV5000 Redefines the Boundaries of Confocal and Multiphoton Imaging

Evident Logo

EVIDENT Launches Sixth Annual Image of the Year Contest

10x Genomics Logo

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research